Trials / Completed
CompletedNCT01500681
Maintenance Plasma Exchange for Neuromyelitis Optica
A Prospective Observational Study of Maintenance Plasma Exchange (PLEX) for Neuromyelitis Optica Spectrum Disorders (MultiPLEX Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system that is associated with autoantibodies to aquaporin-4. Treatment options for prevention of clinical relapses of NMO include immunosuppressive medications. Plasma exchange (PLEX) is commonly used as a rescue therapy for NMO relapses but ongoing, regular PLEX procedures (maintenance PLEX) is sometimes used to prevent relapses. This observational registry will record feasibility, tolerability, safety, and preliminary efficacy data regarding maintenance PLEX for NMO.
Detailed description
Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system that is associated with autoantibodies to aquaporin-4. Treatment options for prevention of clinical relapses of NMO include immunosuppressive medications. Plasma exchange (PLEX) is commonly used as a rescue therapy for NMO relapses but ongoing, regular PLEX procedures (maintenance PLEX) is sometimes used to prevent relapses. This observational registry will record feasibility, tolerability, safety, and preliminary efficacy data regarding maintenance PLEX for participants with NMO, NMO spectrum disorders, and recurrent idiopathic longitudinally extensive transverse myelitis.
Conditions
- Neuromyelitis Optica
- Neuromyelitis Optica Spectrum Disorder
- Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Plasma exchange (PLEX) | Regular maintenance PLEX courses, typically 3 procedures monthly |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2015-07-09
- Completion
- 2015-07-09
- First posted
- 2011-12-28
- Last updated
- 2021-12-27
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01500681. Inclusion in this directory is not an endorsement.